Dentin Hypersensitivity - Varnish or Laser?
Launched by SIGMUND FREUD PRIVATUNIVERSITAT · Aug 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to help people with dentin hypersensitivity, a condition that causes sharp pain in the teeth when exposed to certain triggers like hot or cold temperatures. The goal is to compare the effectiveness of laser treatments with a common desensitizing agent called Gluma to see which option better reduces pain for patients. The study will involve 80 participants who have at least two sensitive teeth and will be divided into four groups, each receiving different treatments.
To be eligible, participants should be between 18 and 70 years old, in good health, and must have at least two sensitive teeth with a pain score above 3 on a scale of 0 to 10. People with certain dental issues, such as active cavities or gum disease, or those who have had recent dental treatments, may not qualify. Throughout the trial, participants will have their pain levels measured before treatment and at various times afterward, allowing researchers to track how well each treatment works. This study is not yet recruiting participants, but it aims to provide helpful insights for those suffering from tooth sensitivity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all genders
- • 18-70 years
- • good general health
- • at least two hypersensitive teeth in either jaw
- • initial VAS-score \>3
- Exclusion Criteria:
- • Active carious lesions, insufficient restorations, enamel cracks, reversible pulpitis
- • Active periodontal disease, periodontal surgery (in the last 6 months)
- • Bleaching procedure in the last 3 months
- • Analgetic use in the last 72 hours
- • Pregnant/lactating women
About Sigmund Freud Privatuniversitat
Sigmund Freud Privatuniversität (SFU) is a leading institution dedicated to advancing the fields of psychology, psychotherapy, and clinical research. Founded on the principles of rigorous academic inquiry and innovative therapeutic practices, SFU fosters a collaborative environment for researchers and practitioners. The university is committed to conducting high-quality clinical trials that contribute to the understanding and treatment of mental health disorders, leveraging its interdisciplinary expertise to enhance patient outcomes and enrich the scientific community. Through its focus on evidence-based practices and ethical research methodologies, SFU aims to promote the integration of theory and practice in the mental health sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported